The objective of this study is to determine if tAN therapy can reduce the volume of blood lost during dialysis AV graft placement procedures.
Participant is undergoing a dialysis port placement procedure using synthetic graft
Participant is between 18 and 75 years of age
Participant is English proficient
Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements
Participant has a BMI ≥ 40
Participant is currently taking a platelet inhibitor medication
Participant has a history of epileptic seizures
Participant has a history of neurological diseases or traumatic brain injury
University Surgical Vascular
Lead sponsor
Spark Biomedical, Inc.
Collaborator